For citations:
Kataeva E.V., Golenkov A.K., Trifonova E.V., Dudina G.A., Mitina T.A., Vysotskaya L.L., Lutskaya T.D., Buravtsova I.V., Gorenkov R.V., Chuksina Yu.Yu., Yazdovskiy V.V. Treatment of patients with refractory chronic lymphocytic leukemia with alemtuzumab, alone or in combination with fludarabine. Oncohematology. 2011;6(2):4-7. (In Russ.) https://doi.org/10.17650/1818-8346-2011-6-2-4-7
Email this article 